Experimental Drug to Offer New Hope for Pediatric Brain Cancers
Tumors within the skull, whether benign or malignant, are particularly dreaded. They cause symptoms like headaches, seizures, nausea and vomiting, behavioral changes and unsteadiness. Benign tumors usually produce symptoms due to the pressure they exert on a part of the brain. An experimental drug, currently referred to as TA228, that is being investigated for the treatment of certain adult cancers, might possibly be useful in the treatment of two fatal brain cancers in children.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer